Finbud Financial
Suresh Kumar Agarwal is no longer listed among Finbud Financial's major shareholders, meaning the previous 4.72 percent stake was either completely sold off or trimmed below the 1 percent reporting threshold.
A loan aggregation platform that connects individuals with banks and non-banking financial companies for personal, business, and home loans across India. Finbud Financial simplifies the borrowing process by enabling customers to access multiple lending options through a single digital interface rather than approaching lenders individually. The company operates as a financial technology intermediary, reducing time and effort required in loan sourcing, comparison, and application processes.
Trained as a homoeopathic physician (M.D. Homoeopathy) and holds postgraduate degrees in law, management, and ecology, then became one of India's most celebrated value investors. Dr. Suresh Kumar Agarwal has been investing since the early 1990s and built a ~₹802 Cr portfolio anchored by NIIT Ltd (~one-third of his book), Caplin Point Laboratories, and Shaily Engineering Plastics. His son Chandan (Cambridge-educated CA) now co-manages the family book. A genuine doctor of the market.